This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
MASLD fibrosis significantly drives HCC risk, study finds
Large patient-level meta-analysis clarifies how fibrosis stage shapes liver cancer risk.
-
03/19/2026
-
by Doug Brunk